A POST-MARKETING SURVEILLANCE STUDY OF 703 PATIENTS TREATED WITH CHIDAMIDE FOR PERIPHERAL T-CELL LYMPHOMA (PTCL) IN CHINA. HDAC STUDY GROUP OF UNION FOR CHINA LYMPHOMA INVESTIGATORS (UCLI)
Ma, J., Zhu, J., Shi, Y.K., Huang, H.Q., Jiang, W.Q., Li, W.Y., Wang, J.H., Xu, W., Hou, M., Jin, Z.M., Liu, T., Liu, P., Zhao, W.L., Zhang, H.L., Yang, H.Y., Zhang, X., Jin, J., Li, Z.M., Qiu, L.G.,Volume:
35
Language:
english
Journal:
Hematological Oncology
DOI:
10.1002/hon.2438_114
Date:
June, 2017
File:
PDF, 128 KB
english, 2017